Kazuhiko Mizukami Selected Research

ASP7657

1/2019	Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.
12/2018	Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiko Mizukami Research Topics

Disease

2	Glomerulonephritis 01/2021 - 08/2014
2	Chronic Renal Insufficiency 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 08/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 01/2003
1	Chronic Limb-Threatening Ischemia 01/2021
1	Ischemia 01/2021
1	Intermittent Claudication 01/2021
1	Inflammation (Inflammations) 01/2021
1	Albuminuria 12/2018
1	Proteinuria 08/2014
1	Nephritis 08/2014
1	Nephrogenic Diabetes Insipidus 01/2003
1	Dehydration (Water Stress) 01/2003
1	Hypertrophy 01/2003
1	Body Weight (Weight, Body) 01/2003
1	Oliguria 01/2003
1	Polyuria 01/2003
1	Acute Kidney Injury (Acute Renal Failure) 01/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2003
2	ASP7657IBA 01/2019 - 12/2018
1	Cilostazol (Pletal)FDA LinkGeneric 01/2021
1	glutaminyl-peptide cyclotransferaseIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	ClusterinIBA 01/2021
1	EP4 Subtype Prostaglandin E ReceptorsIBA 01/2019
1	ReninIBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	pirfenidoneIBA 08/2014
1	antiglomerular basement membrane antibodyIBA 08/2014
1	Messenger RNA (mRNA)IBA 08/2014
1	nephrinIBA 08/2014
1	SodiumIBA 01/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2003
1	Lithium ChlorideIBA 01/2003
1	Furosemide (Lasix)FDA LinkGeneric 01/2003
1	IonsIBA 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2003

Therapy/Procedure

1	Oral Administration 12/2018
1	Nephrectomy 01/2003